Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0LE6M
|
|||
Drug Name |
VLTS-582
|
|||
Synonyms |
gene therapy (MnSOD), Valentis; gene therapy (manganese superoxide dismutase), Valentis
Click to Show/Hide
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Superoxide dismutase Cu-Zn (SOD Cu-Zn) | Target Info | Modulator | [1] |
BioCyc | Reactive oxygen species degradation | |||
KEGG Pathway | Peroxisome | |||
Amyotrophic lateral sclerosis (ALS) | ||||
Huntington's disease | ||||
Prion diseases | ||||
NetPath Pathway | TCR Signaling Pathway | |||
Pathwhiz Pathway | Degradation of Superoxides | |||
Pathway Interaction Database | Validated nuclear estrogen receptor alpha network | |||
FOXA1 transcription factor network | ||||
Reactome | Platelet degranulation | |||
Detoxification of Reactive Oxygen Species | ||||
WikiPathways | Oxidative Stress | |||
Copper homeostasis | ||||
Detoxification of Reactive Oxygen Species | ||||
Nifedipine Activity | ||||
Amyotrophic lateral sclerosis (ALS) | ||||
Dopamine metabolism | ||||
AGE/RAGE pathway | ||||
Folate Metabolism | ||||
Vitamin B12 Metabolism | ||||
Selenium Micronutrient Network |
References | Top | |||
---|---|---|---|---|
REF 1 | A Phase I Study of Concurrent Chemotherapy (Paclitaxel and Carboplatin) and Thoracic Radiotherapy with Swallowed Manganese Superoxide Dismutase Plasmid Liposome Protection in Patients with Locally Advanced Stage III Non-Small-Cell Lung Cancer |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.